OROCETAM
-
| StockNo |
Product description |
| EB0280-410-18 |
OROCETAM
(Piracetam/Orotic acid) AMPOULE 5 ML |
-
- COMPOSITION:
Piracetamum 100 mg and Orotic acid 50 mg in ampoules of 5 ml
ACTION:
Orocetam is a combined preparation possessing marked synergism of
the two components, acting as an antihypnotic drug, enhancing
protein-synthesis and increasing the resistance of the brain cells
against intoxication. Piracetam stimulates macroergic compounds
synthesis, activates bioenergic processes in the mitochondria and
improves local brain circulation. The orotic acid is a precursor for
the pyrimidine bases synthesis, thus taking part in the building of
the nucleic acids and activating the anabolic, detoxic and
regenerative functions.
INDICATIONS:
Orocetam is indicated for treatment of inflammatory and degenerative
diseases of the nervous system, severe brain damage (cranial trauma
in the acute phase, comatose conditions, acute psychic disorders due
to intoxication), acute and chronic alcohol intoxication,
cerebrovascular accident, and other chronic intoxications.
CONTRAINDICATIONS:
Cirrhosis of the liver with ascites, jaundice, and grave renal
damage. |
SIDE EFFECTS:
Allergic dermatitis may be observed. Rarely, sleep disorders are
reported.
PRECAUTIONS:
In cases of liver and renal insufficiency, the residual nitrogen and
the creatinine level must be controlled.
DRUG INTERACTIONS:
Rarely, the effect of the tranquilizers (hyperkinesis) and the oral
anticoagulants may be potentiated.
DOSAGE AND ADMINISTRATION:
One or three ampoules, 2 to 3 times daily, depending on the gravity
of the disease, applied intramuscularly, intravenously or as
infusion.
MEDICINAL FORM AND PACKAGE:
Ampoules of 5 ml, in packs of 50.
STORAGE:
At room temperature (15-30 C).
EXPIRY:
3 (three) years.
|
